nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—PTGS1—kidney cancer	0.291	0.673	CbGaD
Ketamine—ABCB1—kidney cancer	0.142	0.327	CbGaD
Ketamine—ABCB1—Temsirolimus—kidney cancer	0.0358	0.0837	CbGbCtD
Ketamine—CYP3A4—Everolimus—kidney cancer	0.0318	0.0743	CbGbCtD
Ketamine—CYP2C8—Pazopanib—kidney cancer	0.0278	0.065	CbGbCtD
Ketamine—CYP3A4—Temsirolimus—kidney cancer	0.0215	0.0502	CbGbCtD
Ketamine—CYP2B6—Sorafenib—kidney cancer	0.0213	0.0498	CbGbCtD
Ketamine—CYP2C9—Capecitabine—kidney cancer	0.0202	0.0473	CbGbCtD
Ketamine—CYP2C8—Erlotinib—kidney cancer	0.0198	0.0464	CbGbCtD
Ketamine—ABCB1—Pazopanib—kidney cancer	0.0188	0.044	CbGbCtD
Ketamine—CYP2C8—Paclitaxel—kidney cancer	0.0182	0.0424	CbGbCtD
Ketamine—ABCB1—Dactinomycin—kidney cancer	0.0172	0.0402	CbGbCtD
Ketamine—CYP2C8—Sorafenib—kidney cancer	0.0161	0.0377	CbGbCtD
Ketamine—ABCB1—Gemcitabine—kidney cancer	0.0136	0.0318	CbGbCtD
Ketamine—ABCB1—Erlotinib—kidney cancer	0.0134	0.0314	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—kidney cancer	0.0129	0.0302	CbGbCtD
Ketamine—CYP2C9—Paclitaxel—kidney cancer	0.0127	0.0296	CbGbCtD
Ketamine—ABCB1—Paclitaxel—kidney cancer	0.0123	0.0287	CbGbCtD
Ketamine—CYP3A4—Pazopanib—kidney cancer	0.0113	0.0264	CbGbCtD
Ketamine—CYP2C9—Sorafenib—kidney cancer	0.0112	0.0263	CbGbCtD
Ketamine—ABCB1—Sorafenib—kidney cancer	0.0109	0.0255	CbGbCtD
Ketamine—ABCB1—Vinblastine—kidney cancer	0.0108	0.0252	CbGbCtD
Ketamine—ABCB1—Vincristine—kidney cancer	0.0106	0.0248	CbGbCtD
Ketamine—ABCB1—Sunitinib—kidney cancer	0.00884	0.0207	CbGbCtD
Ketamine—CYP3A4—Erlotinib—kidney cancer	0.00804	0.0188	CbGbCtD
Ketamine—CYP3A4—Paclitaxel—kidney cancer	0.00736	0.0172	CbGbCtD
Ketamine—ABCB1—Doxorubicin—kidney cancer	0.00662	0.0155	CbGbCtD
Ketamine—CYP3A4—Sorafenib—kidney cancer	0.00654	0.0153	CbGbCtD
Ketamine—CYP3A4—Vinblastine—kidney cancer	0.00646	0.0151	CbGbCtD
Ketamine—CYP3A4—Vincristine—kidney cancer	0.00635	0.0148	CbGbCtD
Ketamine—CYP3A4—Sunitinib—kidney cancer	0.0053	0.0124	CbGbCtD
Ketamine—CYP3A4—Doxorubicin—kidney cancer	0.00397	0.00928	CbGbCtD
Ketamine—Nystagmus—Vinblastine—kidney cancer	0.00179	0.0313	CcSEcCtD
Ketamine—Cystitis noninfective—Temsirolimus—kidney cancer	0.00168	0.0292	CcSEcCtD
Ketamine—Cystitis—Temsirolimus—kidney cancer	0.00166	0.0289	CcSEcCtD
Ketamine—Bladder pain—Temsirolimus—kidney cancer	0.00155	0.0271	CcSEcCtD
Ketamine—Nystagmus—Vincristine—kidney cancer	0.00126	0.022	CcSEcCtD
Ketamine—Bladder pain—Everolimus—kidney cancer	0.00115	0.0201	CcSEcCtD
Ketamine—Bradycardia—Pazopanib—kidney cancer	0.000827	0.0144	CcSEcCtD
Ketamine—Erythema—Temsirolimus—kidney cancer	0.00075	0.0131	CcSEcCtD
Ketamine—Erythema—Pazopanib—kidney cancer	0.000707	0.0123	CcSEcCtD
Ketamine—Vision blurred—Pazopanib—kidney cancer	0.000666	0.0116	CcSEcCtD
Ketamine—Convulsion—Temsirolimus—kidney cancer	0.00065	0.0113	CcSEcCtD
Ketamine—Anaphylactic shock—Temsirolimus—kidney cancer	0.000612	0.0107	CcSEcCtD
Ketamine—Anorexia—Temsirolimus—kidney cancer	0.000584	0.0102	CcSEcCtD
Ketamine—Shock—Pazopanib—kidney cancer	0.000568	0.0099	CcSEcCtD
Ketamine—Erythema—Everolimus—kidney cancer	0.000558	0.00973	CcSEcCtD
Ketamine—Arrhythmia—Erlotinib—kidney cancer	0.000553	0.00964	CcSEcCtD
Ketamine—Anorexia—Pazopanib—kidney cancer	0.00055	0.00959	CcSEcCtD
Ketamine—Bradycardia—Sunitinib—kidney cancer	0.000545	0.00951	CcSEcCtD
Ketamine—Erythema—Erlotinib—kidney cancer	0.000538	0.00939	CcSEcCtD
Ketamine—Decreased appetite—Temsirolimus—kidney cancer	0.000532	0.00928	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—kidney cancer	0.000531	0.00925	CcSEcCtD
Ketamine—Vision blurred—Everolimus—kidney cancer	0.000526	0.00917	CcSEcCtD
Ketamine—Pain—Temsirolimus—kidney cancer	0.000524	0.00913	CcSEcCtD
Ketamine—Decreased appetite—Pazopanib—kidney cancer	0.000501	0.00875	CcSEcCtD
Ketamine—Arrhythmia—Sorafenib—kidney cancer	0.000497	0.00867	CcSEcCtD
Ketamine—Pain—Pazopanib—kidney cancer	0.000493	0.0086	CcSEcCtD
Ketamine—Convulsion—Vinblastine—kidney cancer	0.000485	0.00847	CcSEcCtD
Ketamine—Erythema—Sorafenib—kidney cancer	0.000484	0.00845	CcSEcCtD
Ketamine—Convulsion—Everolimus—kidney cancer	0.000484	0.00843	CcSEcCtD
Ketamine—Arrhythmia—Sunitinib—kidney cancer	0.000478	0.00834	CcSEcCtD
Ketamine—Erythema—Sunitinib—kidney cancer	0.000466	0.00813	CcSEcCtD
Ketamine—Shock—Everolimus—kidney cancer	0.000448	0.00782	CcSEcCtD
Ketamine—Erythema—Dactinomycin—kidney cancer	0.000441	0.0077	CcSEcCtD
Ketamine—Anorexia—Vinblastine—kidney cancer	0.000436	0.0076	CcSEcCtD
Ketamine—Anorexia—Everolimus—kidney cancer	0.000434	0.00757	CcSEcCtD
Ketamine—Shock—Erlotinib—kidney cancer	0.000432	0.00754	CcSEcCtD
Ketamine—Diplopia—Capecitabine—kidney cancer	0.000427	0.00744	CcSEcCtD
Ketamine—Hypotension—Everolimus—kidney cancer	0.000426	0.00742	CcSEcCtD
Ketamine—Anorexia—Erlotinib—kidney cancer	0.000419	0.00731	CcSEcCtD
Ketamine—Convulsion—Sunitinib—kidney cancer	0.000404	0.00704	CcSEcCtD
Ketamine—Decreased appetite—Vinblastine—kidney cancer	0.000397	0.00693	CcSEcCtD
Ketamine—Decreased appetite—Everolimus—kidney cancer	0.000396	0.00691	CcSEcCtD
Ketamine—Anaphylactic shock—Sorafenib—kidney cancer	0.000395	0.0069	CcSEcCtD
Ketamine—Pain—Vinblastine—kidney cancer	0.000391	0.00682	CcSEcCtD
Ketamine—Pain—Everolimus—kidney cancer	0.00039	0.00679	CcSEcCtD
Ketamine—Vomiting—Temsirolimus—kidney cancer	0.000389	0.00679	CcSEcCtD
Ketamine—Shock—Sorafenib—kidney cancer	0.000389	0.00678	CcSEcCtD
Ketamine—Rash—Temsirolimus—kidney cancer	0.000386	0.00673	CcSEcCtD
Ketamine—Dermatitis—Temsirolimus—kidney cancer	0.000386	0.00673	CcSEcCtD
Ketamine—Arrhythmia—Gemcitabine—kidney cancer	0.000384	0.00669	CcSEcCtD
Ketamine—Decreased appetite—Erlotinib—kidney cancer	0.000382	0.00666	CcSEcCtD
Ketamine—Anorexia—Sorafenib—kidney cancer	0.000377	0.00657	CcSEcCtD
Ketamine—Pain—Erlotinib—kidney cancer	0.000376	0.00655	CcSEcCtD
Ketamine—Shock—Sunitinib—kidney cancer	0.000374	0.00653	CcSEcCtD
Ketamine—Erythema—Gemcitabine—kidney cancer	0.000374	0.00652	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—kidney cancer	0.00037	0.00646	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000368	0.00642	CcSEcCtD
Ketamine—Vomiting—Pazopanib—kidney cancer	0.000367	0.0064	CcSEcCtD
Ketamine—Bradycardia—Paclitaxel—kidney cancer	0.000366	0.00639	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—kidney cancer	0.000366	0.00638	CcSEcCtD
Ketamine—Rash—Pazopanib—kidney cancer	0.000364	0.00634	CcSEcCtD
Ketamine—Nausea—Temsirolimus—kidney cancer	0.000364	0.00634	CcSEcCtD
Ketamine—Dermatitis—Pazopanib—kidney cancer	0.000363	0.00634	CcSEcCtD
Ketamine—Anorexia—Sunitinib—kidney cancer	0.000363	0.00632	CcSEcCtD
Ketamine—Decreased appetite—Sorafenib—kidney cancer	0.000344	0.00599	CcSEcCtD
Ketamine—Anorexia—Dactinomycin—kidney cancer	0.000343	0.00599	CcSEcCtD
Ketamine—Nausea—Pazopanib—kidney cancer	0.000343	0.00598	CcSEcCtD
Ketamine—Bladder pain—Doxorubicin—kidney cancer	0.000343	0.00598	CcSEcCtD
Ketamine—Convulsion—Vincristine—kidney cancer	0.000342	0.00596	CcSEcCtD
Ketamine—Pain—Sorafenib—kidney cancer	0.000338	0.0059	CcSEcCtD
Ketamine—Decreased appetite—Sunitinib—kidney cancer	0.000331	0.00577	CcSEcCtD
Ketamine—Pain—Sunitinib—kidney cancer	0.000325	0.00567	CcSEcCtD
Ketamine—Anaphylactic shock—Vincristine—kidney cancer	0.000322	0.00561	CcSEcCtD
Ketamine—Arrhythmia—Paclitaxel—kidney cancer	0.000321	0.0056	CcSEcCtD
Ketamine—Erythema—Paclitaxel—kidney cancer	0.000313	0.00546	CcSEcCtD
Ketamine—Decreased appetite—Dactinomycin—kidney cancer	0.000313	0.00546	CcSEcCtD
Ketamine—Pain—Dactinomycin—kidney cancer	0.000308	0.00537	CcSEcCtD
Ketamine—Anorexia—Vincristine—kidney cancer	0.000307	0.00535	CcSEcCtD
Ketamine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000305	0.00532	CcSEcCtD
Ketamine—Hypotension—Vincristine—kidney cancer	0.000301	0.00524	CcSEcCtD
Ketamine—Bradycardia—Capecitabine—kidney cancer	0.000301	0.00524	CcSEcCtD
Ketamine—Vision blurred—Paclitaxel—kidney cancer	0.000295	0.00515	CcSEcCtD
Ketamine—Anorexia—Gemcitabine—kidney cancer	0.000291	0.00507	CcSEcCtD
Ketamine—Vomiting—Vinblastine—kidney cancer	0.000291	0.00507	CcSEcCtD
Ketamine—Vomiting—Everolimus—kidney cancer	0.00029	0.00505	CcSEcCtD
Ketamine—Rash—Everolimus—kidney cancer	0.000287	0.00501	CcSEcCtD
Ketamine—Dermatitis—Everolimus—kidney cancer	0.000287	0.005	CcSEcCtD
Ketamine—Hypotension—Gemcitabine—kidney cancer	0.000285	0.00497	CcSEcCtD
Ketamine—Decreased appetite—Vincristine—kidney cancer	0.00028	0.00488	CcSEcCtD
Ketamine—Vomiting—Erlotinib—kidney cancer	0.000279	0.00487	CcSEcCtD
Ketamine—Rash—Erlotinib—kidney cancer	0.000277	0.00483	CcSEcCtD
Ketamine—Dermatitis—Erlotinib—kidney cancer	0.000277	0.00483	CcSEcCtD
Ketamine—Pain—Vincristine—kidney cancer	0.000275	0.0048	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—kidney cancer	0.000275	0.0048	CcSEcCtD
Ketamine—Nausea—Vinblastine—kidney cancer	0.000272	0.00474	CcSEcCtD
Ketamine—Convulsion—Paclitaxel—kidney cancer	0.000271	0.00473	CcSEcCtD
Ketamine—Nausea—Everolimus—kidney cancer	0.000271	0.00472	CcSEcCtD
Ketamine—Decreased appetite—Gemcitabine—kidney cancer	0.000265	0.00463	CcSEcCtD
Ketamine—Arrhythmia—Capecitabine—kidney cancer	0.000264	0.0046	CcSEcCtD
Ketamine—Pain—Gemcitabine—kidney cancer	0.000261	0.00455	CcSEcCtD
Ketamine—Nausea—Erlotinib—kidney cancer	0.000261	0.00455	CcSEcCtD
Ketamine—Erythema—Capecitabine—kidney cancer	0.000257	0.00448	CcSEcCtD
Ketamine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000256	0.00446	CcSEcCtD
Ketamine—Shock—Paclitaxel—kidney cancer	0.000251	0.00439	CcSEcCtD
Ketamine—Vomiting—Sorafenib—kidney cancer	0.000251	0.00438	CcSEcCtD
Ketamine—Rash—Sorafenib—kidney cancer	0.000249	0.00435	CcSEcCtD
Ketamine—Dermatitis—Sorafenib—kidney cancer	0.000249	0.00434	CcSEcCtD
Ketamine—Anorexia—Paclitaxel—kidney cancer	0.000244	0.00425	CcSEcCtD
Ketamine—Vision blurred—Capecitabine—kidney cancer	0.000242	0.00422	CcSEcCtD
Ketamine—Vomiting—Sunitinib—kidney cancer	0.000242	0.00422	CcSEcCtD
Ketamine—Rash—Sunitinib—kidney cancer	0.00024	0.00418	CcSEcCtD
Ketamine—Dermatitis—Sunitinib—kidney cancer	0.00024	0.00418	CcSEcCtD
Ketamine—Hypotension—Paclitaxel—kidney cancer	0.000239	0.00417	CcSEcCtD
Ketamine—Nausea—Sorafenib—kidney cancer	0.000235	0.0041	CcSEcCtD
Ketamine—Vomiting—Dactinomycin—kidney cancer	0.000229	0.00399	CcSEcCtD
Ketamine—Rash—Dactinomycin—kidney cancer	0.000227	0.00396	CcSEcCtD
Ketamine—Nausea—Sunitinib—kidney cancer	0.000226	0.00394	CcSEcCtD
Ketamine—Decreased appetite—Paclitaxel—kidney cancer	0.000222	0.00387	CcSEcCtD
Ketamine—Pain—Paclitaxel—kidney cancer	0.000219	0.00381	CcSEcCtD
Ketamine—Nausea—Dactinomycin—kidney cancer	0.000214	0.00373	CcSEcCtD
Ketamine—Shock—Capecitabine—kidney cancer	0.000206	0.0036	CcSEcCtD
Ketamine—Vomiting—Vincristine—kidney cancer	0.000205	0.00357	CcSEcCtD
Ketamine—Rash—Vincristine—kidney cancer	0.000203	0.00354	CcSEcCtD
Ketamine—Dermatitis—Vincristine—kidney cancer	0.000203	0.00354	CcSEcCtD
Ketamine—Anorexia—Capecitabine—kidney cancer	0.0002	0.00349	CcSEcCtD
Ketamine—Hypotension—Capecitabine—kidney cancer	0.000196	0.00342	CcSEcCtD
Ketamine—Vomiting—Gemcitabine—kidney cancer	0.000194	0.00339	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—kidney cancer	0.000194	0.00338	CcSEcCtD
Ketamine—Rash—Gemcitabine—kidney cancer	0.000192	0.00336	CcSEcCtD
Ketamine—Dermatitis—Gemcitabine—kidney cancer	0.000192	0.00335	CcSEcCtD
Ketamine—Nausea—Vincristine—kidney cancer	0.000191	0.00333	CcSEcCtD
Ketamine—Decreased appetite—Capecitabine—kidney cancer	0.000182	0.00318	CcSEcCtD
Ketamine—Nausea—Gemcitabine—kidney cancer	0.000181	0.00316	CcSEcCtD
Ketamine—Pain—Capecitabine—kidney cancer	0.000179	0.00313	CcSEcCtD
Ketamine—Arrhythmia—Doxorubicin—kidney cancer	0.00017	0.00296	CcSEcCtD
Ketamine—Erythema—Doxorubicin—kidney cancer	0.000166	0.00289	CcSEcCtD
Ketamine—Vomiting—Paclitaxel—kidney cancer	0.000163	0.00283	CcSEcCtD
Ketamine—Rash—Paclitaxel—kidney cancer	0.000161	0.00281	CcSEcCtD
Ketamine—Dermatitis—Paclitaxel—kidney cancer	0.000161	0.00281	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—kidney cancer	0.000156	0.00272	CcSEcCtD
Ketamine—Nausea—Paclitaxel—kidney cancer	0.000152	0.00265	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—kidney cancer	0.000144	0.0025	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000135	0.00236	CcSEcCtD
Ketamine—Vomiting—Capecitabine—kidney cancer	0.000133	0.00233	CcSEcCtD
Ketamine—Shock—Doxorubicin—kidney cancer	0.000133	0.00232	CcSEcCtD
Ketamine—Rash—Capecitabine—kidney cancer	0.000132	0.00231	CcSEcCtD
Ketamine—Dermatitis—Capecitabine—kidney cancer	0.000132	0.0023	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—kidney cancer	0.000129	0.00225	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—kidney cancer	0.000126	0.0022	CcSEcCtD
Ketamine—Nausea—Capecitabine—kidney cancer	0.000125	0.00217	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—kidney cancer	0.000118	0.00205	CcSEcCtD
Ketamine—Pain—Doxorubicin—kidney cancer	0.000116	0.00202	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—kidney cancer	8.6e-05	0.0015	CcSEcCtD
Ketamine—Rash—Doxorubicin—kidney cancer	8.52e-05	0.00149	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—kidney cancer	8.52e-05	0.00149	CcSEcCtD
Ketamine—Nausea—Doxorubicin—kidney cancer	8.03e-05	0.0014	CcSEcCtD
Ketamine—OPRD1—Signaling Pathways—KDR—kidney cancer	1.02e-05	0.000125	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APRT—kidney cancer	1.02e-05	0.000125	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FH—kidney cancer	1.02e-05	0.000125	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTP1—kidney cancer	1.02e-05	0.000125	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—kidney cancer	1e-05	0.000122	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF2—kidney cancer	9.97e-06	0.000122	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FLT1—kidney cancer	9.97e-06	0.000122	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN2B—kidney cancer	9.93e-06	0.000121	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—kidney cancer	9.86e-06	0.00012	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.86e-06	0.00012	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BCHE—kidney cancer	9.8e-06	0.00012	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CRABP1—kidney cancer	9.79e-06	0.00012	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC5A5—kidney cancer	9.68e-06	0.000118	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ABCB1—kidney cancer	9.67e-06	0.000118	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1R—kidney cancer	9.64e-06	0.000118	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.63e-06	0.000118	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPC3—kidney cancer	9.62e-06	0.000118	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.53e-06	0.000117	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ACHE—kidney cancer	9.52e-06	0.000116	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTT1—kidney cancer	9.52e-06	0.000116	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK3—kidney cancer	9.48e-06	0.000116	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—APC—kidney cancer	9.44e-06	0.000115	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KIT—kidney cancer	9.44e-06	0.000115	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—POMC—kidney cancer	9.4e-06	0.000115	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HIF1A—kidney cancer	9.39e-06	0.000115	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GSTM1—kidney cancer	9.39e-06	0.000115	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TSC2—kidney cancer	9.37e-06	0.000115	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CA2—kidney cancer	9.36e-06	0.000114	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC2A1—kidney cancer	9.35e-06	0.000114	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—RAF1—kidney cancer	9.29e-06	0.000114	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUNB—kidney cancer	9.25e-06	0.000113	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PAK1—kidney cancer	9.25e-06	0.000113	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—kidney cancer	9.22e-06	0.000113	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—kidney cancer	9.17e-06	0.000112	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CRABP1—kidney cancer	9.14e-06	0.000112	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALAD—kidney cancer	9.12e-06	0.000111	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ITPR2—kidney cancer	9.1e-06	0.000111	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	9.04e-06	0.00011	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MAPK1—kidney cancer	9.02e-06	0.00011	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SCARB1—kidney cancer	9.01e-06	0.00011	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—POMC—kidney cancer	8.98e-06	0.00011	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KDR—kidney cancer	8.98e-06	0.00011	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS1—kidney cancer	8.92e-06	0.000109	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYP1A1—kidney cancer	8.9e-06	0.000109	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.9e-06	0.000109	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—BRAF—kidney cancer	8.87e-06	0.000108	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PSMD7—kidney cancer	8.75e-06	0.000107	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.7e-06	0.000106	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	8.6e-06	0.000105	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—POMC—kidney cancer	8.54e-06	0.000104	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KRAS—kidney cancer	8.52e-06	0.000104	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ITPR2—kidney cancer	8.5e-06	0.000104	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.34e-06	0.000102	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PGK1—kidney cancer	8.34e-06	0.000102	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—kidney cancer	8.33e-06	0.000102	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ACHE—kidney cancer	8.3e-06	0.000101	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTT1—kidney cancer	8.3e-06	0.000101	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BCHE—kidney cancer	8.3e-06	0.000101	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KIT—kidney cancer	8.28e-06	0.000101	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APC—kidney cancer	8.28e-06	0.000101	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	8.22e-06	0.0001	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.19e-06	0.0001	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LDHB—kidney cancer	8.18e-06	0.0001	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—KRAS—kidney cancer	8.12e-06	9.93e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HIF1A—kidney cancer	7.94e-06	9.7e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	7.93e-06	9.69e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TSC2—kidney cancer	7.92e-06	9.68e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC2A1—kidney cancer	7.91e-06	9.67e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—POMC—kidney cancer	7.88e-06	9.63e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SCARB1—kidney cancer	7.85e-06	9.6e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.83e-06	9.58e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PIK3CA—kidney cancer	7.83e-06	9.57e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTP1—kidney cancer	7.8e-06	9.53e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—BRAF—kidney cancer	7.78e-06	9.51e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS1—kidney cancer	7.77e-06	9.5e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTT1—kidney cancer	7.75e-06	9.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ACHE—kidney cancer	7.75e-06	9.47e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.68e-06	9.39e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PSMD7—kidney cancer	7.62e-06	9.32e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KDR—kidney cancer	7.59e-06	9.28e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—kidney cancer	7.57e-06	9.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF2—kidney cancer	7.56e-06	9.24e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	7.54e-06	9.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN2B—kidney cancer	7.53e-06	9.2e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	7.46e-06	9.12e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RAF1—kidney cancer	7.41e-06	9.05e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCB1—kidney cancer	7.38e-06	9.02e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RELA—kidney cancer	7.37e-06	9.01e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SCARB1—kidney cancer	7.34e-06	8.97e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB2—kidney cancer	7.33e-06	8.96e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.31e-06	8.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1R—kidney cancer	7.31e-06	8.93e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS1—kidney cancer	7.26e-06	8.88e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MTOR—kidney cancer	7.23e-06	8.84e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BCHE—kidney cancer	7.23e-06	8.83e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	7.21e-06	8.81e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GSTM1—kidney cancer	7.16e-06	8.76e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC5A5—kidney cancer	7.14e-06	8.73e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—KRAS—kidney cancer	7.12e-06	8.71e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PSMD7—kidney cancer	7.12e-06	8.71e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CA9—kidney cancer	7.09e-06	8.67e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RAF1—kidney cancer	7.04e-06	8.61e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APC—kidney cancer	6.99e-06	8.55e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KIT—kidney cancer	6.99e-06	8.55e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—kidney cancer	6.95e-06	8.5e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A1—kidney cancer	6.89e-06	8.43e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYP1A1—kidney cancer	6.79e-06	8.3e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	6.79e-06	8.29e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BCHE—kidney cancer	6.75e-06	8.25e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	6.7e-06	8.19e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.7e-06	8.18e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.67e-06	8.15e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—POMC—kidney cancer	6.66e-06	8.14e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—kidney cancer	6.64e-06	8.12e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—POMC—kidney cancer	6.64e-06	8.11e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTP1—kidney cancer	6.6e-06	8.07e-05	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.57e-06	8.04e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BRAF—kidney cancer	6.57e-06	8.04e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	6.54e-06	8e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RAF1—kidney cancer	6.49e-06	7.94e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—kidney cancer	6.47e-06	7.91e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RELA—kidney cancer	6.47e-06	7.9e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JUN—kidney cancer	6.46e-06	7.9e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.44e-06	7.87e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—kidney cancer	6.43e-06	7.85e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	6.41e-06	7.84e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	6.37e-06	7.79e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MTOR—kidney cancer	6.34e-06	7.75e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—kidney cancer	6.31e-06	7.72e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.25e-06	7.64e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTEN—kidney cancer	6.25e-06	7.64e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—kidney cancer	6.25e-06	7.64e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	6.09e-06	7.44e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTM1—kidney cancer	6.07e-06	7.41e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CRABP1—kidney cancer	6.03e-06	7.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—kidney cancer	6.02e-06	7.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HIF1A—kidney cancer	6.02e-06	7.35e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TSC2—kidney cancer	6e-06	7.34e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	5.95e-06	7.27e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—kidney cancer	5.82e-06	7.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—kidney cancer	5.75e-06	7.03e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTP1—kidney cancer	5.75e-06	7.03e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.75e-06	7.03e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—kidney cancer	5.68e-06	6.94e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—kidney cancer	5.66e-06	6.92e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—kidney cancer	5.64e-06	6.9e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	5.62e-06	6.87e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ITPR2—kidney cancer	5.6e-06	6.85e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	5.53e-06	6.76e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RAF1—kidney cancer	5.49e-06	6.71e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—kidney cancer	5.48e-06	6.7e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RELA—kidney cancer	5.46e-06	6.68e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.45e-06	6.66e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—kidney cancer	5.43e-06	6.64e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTP1—kidney cancer	5.37e-06	6.57e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MTOR—kidney cancer	5.36e-06	6.55e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—kidney cancer	5.34e-06	6.53e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—kidney cancer	5.3e-06	6.48e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—kidney cancer	5.3e-06	6.48e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—kidney cancer	5.29e-06	6.47e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—kidney cancer	5.28e-06	6.46e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—kidney cancer	5.19e-06	6.35e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTT1—kidney cancer	5.11e-06	6.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ACHE—kidney cancer	5.11e-06	6.25e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—kidney cancer	5.09e-06	6.22e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK1—kidney cancer	5.08e-06	6.21e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—kidney cancer	5.08e-06	6.2e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—POMC—kidney cancer	5.06e-06	6.19e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—POMC—kidney cancer	5.05e-06	6.17e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	5.03e-06	6.15e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1A1—kidney cancer	5.01e-06	6.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—kidney cancer	4.98e-06	6.09e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—kidney cancer	4.95e-06	6.05e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—kidney cancer	4.94e-06	6.03e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—kidney cancer	4.92e-06	6.02e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SCARB1—kidney cancer	4.84e-06	5.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK1—kidney cancer	4.83e-06	5.9e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—kidney cancer	4.8e-06	5.86e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—kidney cancer	4.8e-06	5.86e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS1—kidney cancer	4.79e-06	5.85e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—kidney cancer	4.79e-06	5.85e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	4.75e-06	5.81e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.72e-06	5.77e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.7e-06	5.74e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—kidney cancer	4.68e-06	5.72e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.68e-06	5.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—kidney cancer	4.63e-06	5.66e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—kidney cancer	4.62e-06	5.64e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	4.62e-06	5.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—kidney cancer	4.56e-06	5.58e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—kidney cancer	4.55e-06	5.57e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK1—kidney cancer	4.45e-06	5.44e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BCHE—kidney cancer	4.45e-06	5.44e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	4.41e-06	5.39e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.4e-06	5.38e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—POMC—kidney cancer	4.29e-06	5.24e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—kidney cancer	4.26e-06	5.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.25e-06	5.19e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—kidney cancer	4.21e-06	5.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	4.19e-06	5.12e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—kidney cancer	4.18e-06	5.11e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RAF1—kidney cancer	4.16e-06	5.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RELA—kidney cancer	4.14e-06	5.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—kidney cancer	4.12e-06	5.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MTOR—kidney cancer	4.06e-06	4.96e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—kidney cancer	4.04e-06	4.94e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—kidney cancer	3.96e-06	4.84e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	3.87e-06	4.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—kidney cancer	3.85e-06	4.7e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.84e-06	4.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.81e-06	4.66e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK1—kidney cancer	3.76e-06	4.6e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—kidney cancer	3.74e-06	4.57e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—POMC—kidney cancer	3.73e-06	4.57e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—kidney cancer	3.73e-06	4.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—kidney cancer	3.64e-06	4.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—kidney cancer	3.63e-06	4.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.6e-06	4.4e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—kidney cancer	3.56e-06	4.35e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.54e-06	4.33e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—kidney cancer	3.52e-06	4.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—kidney cancer	3.51e-06	4.29e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—POMC—kidney cancer	3.49e-06	4.26e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—kidney cancer	3.42e-06	4.18e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.35e-06	4.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	3.27e-06	3.99e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—kidney cancer	3.26e-06	3.98e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.26e-06	3.98e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.17e-06	3.87e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—kidney cancer	3.16e-06	3.86e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.09e-06	3.77e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3e-06	3.67e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—kidney cancer	2.98e-06	3.65e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—kidney cancer	2.98e-06	3.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—kidney cancer	2.92e-06	3.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.85e-06	3.49e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—kidney cancer	2.78e-06	3.4e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—kidney cancer	2.69e-06	3.29e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—kidney cancer	2.6e-06	3.18e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—kidney cancer	2.48e-06	3.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	3.03e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—kidney cancer	2.43e-06	2.97e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—kidney cancer	2.4e-06	2.93e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—POMC—kidney cancer	2.3e-06	2.81e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.1e-06	2.57e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.84e-06	2.24e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.83e-06	2.24e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.71e-06	2.09e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—kidney cancer	1.6e-06	1.96e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.13e-06	1.38e-05	CbGpPWpGaD
